Results 161 to 170 of about 32,662,171 (307)

Replication Data for: Automating Urban Soundscape Enhancements with AI: In-situ Assessment of Quality and Restorativeness in Traffic-Exposed Residential Areas

This dataset contains the following data tables: amss_insitu_participant_data.csv: Participant responses to site evaluation comb_obj_insitu_session_data.csv: Per session combined objective acoustic measurement and subjective response data The ...
Ooi, Kenneth, Gan, Woon-Seng, Ong, Zhen-Ting, Lee, Irene, Boey, Vanessa, Lam, Bhan   +5 more
core   +1 more source

Circular RNA expression landscapes in myelodysplastic neoplasms: Associations with mutational signatures and disease progression

Molecular Oncology, EarlyView.
In this explorative study, the abundance of circular RNA molecules in bone marrow stem cells was found to be elevated in patients with high‐risk myelodysplastic neoplasms, and to be associated with an increased risk of progression to acute myeloid leukemia.
Eileen Wedge, Morten Tulstrup, Gabriele Todisco, Pedro Moura, Christophe Côme, Jakob Werner Hansen, Jakob Schmidt Jespersen, Balthasar Schlotmann, Maria Creignou, Mette Dahl, Claudia Schöllkopf, Klas Raaschou‐Jensen, Krister Wennerberg, Bo Porse, Joachim Weischenfeldt, Eva Hellström‐Lindberg, Lasse Sommer Kristensen, Kirsten Grønbæk   +17 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

Molecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla, Christopher Dirks, Caroline Eiden, Sonja K. Fesenmayer, Femke M. Hormann, Yolande Klootsema, Ingrid Lilienthal, Si Min Zhang, Nikolas Herold, Sean G. Rudd   +9 more
wiley   +1 more source

National Cancer Patient Experience Survey, 2015

, 2017
copyright UK Data Service and data collection copyright owner.The National Cancer Patient Experience Surveys (NCPES) began in 2010, after the 2007 'Cancer Reform Strategy' set out a commitment to establish a new survey programme. The NCPES is intended to
Quality Health, NHS England
core  

The fundamentals of eye tracking, Part 7: Determining data quality. [PDF]

Behav Res Methods
Niehorster DC, Nyström M, Hessels RS, Benjamins JS, Andersson R, Hooge ITC.   +5 more
europepmc   +1 more source

Differential expression of cancer‐related genes supports prediction of poor response to first‐line treatments in T‐ALL pediatric patients with high minimal residual disease

Molecular Oncology, EarlyView.
In the present work, we have identified a transcriptional signature based on the differential expression of six genes (BCL2&MAST4, HSH2D&LAT2, METRN&PITPNM2) that would facilitate the early detection of T‐cell acute lymphoblastic leukemia (T‐ALL) patients prone to a poor treatment response and could be implemented at diagnosis, along with other risk ...
Antonio Lahera, Laura Vela‐Martín, Pablo Fernández‐Navarro, José Luis López‐Lorenzo, Javier Cornago, Pilar Llamas, Eduardo Pérez‐Gómez, José Luis Marín‐Rubio, Manuel Fresno, Javier Santos, José Fernández‐Piqueras, María Villa‐Morales   +11 more
wiley   +1 more source

Theoretical Study of Am(III) and Eu(III) Separation by a Bipyridyl Phosphate Ligand

ACS Omega
Xinyi Zhang, Lulu Ye, Weihao Chen, Xiaofei Zhang, Weiwei Chen, Miaogen Chen, Pinwen Huang   +6 more
doaj   +1 more source

[Data--quality--quality of data].

Tidsskrift for den Norske laegeforening : tidsskrift for praktisk medicin, ny raekke, 1995
O F, Sellevold, S, Fasting
openaire   +1 more source

Improving Trauma Data Quality in Rwanda: A Prospective Assessment of Registry Completeness and Accuracy. [PDF]

J Clin Med
Ntezimana JN, Welgama I, Nuhu A, Bagahirwa I, Umuhoza V, Iradukunda F, Ghalichi L, Sheferaw ED, Davies JI, Byiringiro JC.   +9 more
europepmc   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

Molecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan, Veronika M Metzler, Simone de Brot, Corinne L Woodcock, Anna E Harris, Jennifer Lothion‐Roy, Emeli M Nilsson, Atara Ntekim, Michael S Toss, Jenny L Persson, Francesca Khani, Brian D Robinson, Lorraine J Gudas, Emad Rakha, David M Heery, Catrin S Rutland, Nigel P Mongan   +16 more
wiley   +1 more source